THE PRACTICAL CONSEQUENCES OF THE CHANGE OF THE HOME OFFICE’S POLICY ON CONTROLLED CANNABINOIDS CONTENT IN CBD PRODUCTS
Please wait, loading...
THE PRACTICAL CONSEQUENCES OF THE CHANGE OF THE HOME OFFICE’S POLICY ON CONTROLLED CANNABINOIDS CONTENT IN CBD PRODUCTS
A SURPRISING ABOUT-TURN IN HOME OFFICE POLICY IN RESPECT OF “EXEMPT PRODUCTS” UNDER THE MISUSE OF DRUGS REGULATIONS
For the past 4 years, DevelRx and The Canna Consultants have worked in collaboration with the goal of achieving an objective and scientifically valid assessment the safety risks posed by the introduction of CBD as a novel food or food supplement.
THE FSA’s STANCE ON THE PUBLIC LIST FOLLOWING THEIR ADVICE TO LIMIT CBD INGESTION TO 10mg PER DAY – A CONTRADICTION IN TERMS
ADVICE REGARDING THE FSA’s REDUCTION IN THE RECOMMENDED DAILY INTAKE OF CBD FOLLOWING A MEETING WITH THEM HELD TODAY
THE WHOLE OF THE UK CBD INDUSTRY SUFFERS THE COLLATERAL DAMAGE CAUSED BY ONE CONSORTIUM’S POORLY DESIGNED STUDY
RESPONSE TO THE ATTACK ON OUR INTEGRITY BY THE ASSOCIATION FOR THE CANNABINOID INDUSTRY
The revocation of Jersey Hemp's cultivation, extraction and export licences by the Government of Jersey (at the behest of the UK Government) is unfortunate for all those involved in the business, but it is no surprise – it was inevitable.
This week alerted the wider CBD market to some old issues which we had been repeatedly raising with participants who were either already subscribed to the EIHA application or were the recipients of invitations to join the application, plus a considerable new issue around the EIHA Toxicology Consortium results.
For many, many months now we at The Canna Consultants have we have repeatedly informed market participants that those who had subscribed to the EIHA Toxicology Consortium were going to get a Rude Awakening...